Growth and Puberty: A clinical approach. Dr Esko Wiltshire

Similar documents
Growth hormone therapy in a girl with Turner syndrome showing a large increase over the initially predicted ht of 4 5

PedsCases Podcast Scripts

Why is my body not changing? Conflicts of interest. Overview 11/9/2015. None

Puberty and Pubertal Disorders Part 3: Delayed Puberty

PedsCases Podcast Scripts

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland

Diagnosing Growth Disorders. PE Clayton School of Medical Sciences, Faculty of Biology, Medicine & Health

OBJECTIVES. Rebecca McEachern, MD. Puberty: Too early, Too Late or Just Right? Special Acknowledgements. Maryann Johnson M.Ed.

PUBERTY. Preetha Krishnamoorthy. Division of Pediatric Endocrinology

Puberty and Pubertal Disorders. Lisa Swartz Topor, MD, MMSc Pediatric Endocrinology July 2018

Precocious Puberty. Disclosures. No financial disclosures 2/28/2019

Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

Growth Hormones DRUG.00009

The Patient with Turner s syndrome: Care in the Adult Clinic. Dr Siobhán McQuaid Consultant Endocrinologist Mater Misericordiae University Hospital

Growth Hormone plus Childhood Low- Dose Estrogen in Turner s Syndrome. N Engl J Med 2011;364: Present by R5 郭恬妮

How to approach a child with growth concern

The University of Arizona Pediatric Residency Program. Primary Goals for Rotation. Endocrinology

Reproductive Health and Pituitary Disease

2. Has this plan authorized this medication in the past for this member (i.e., previous authorization is on file under this plan)?

Request for Prior Authorization Growth Hormone (Norditropin

Endocrine Quiz / overview. Endocrine Quiz. Pituitary insufficiency. Genetic causes of hypopituitarism. Acquired MPHD Order of hormone loss..

Clinical Standards for GH Treatment in Childhood & Adolescence.

2.0 Synopsis. Lupron Depot M Clinical Study Report R&D/09/093. (For National Authority Use Only) to Part of Dossier: Name of Study Drug:

GH therapy in PWS (& other endocrine problems) Dr. Shankar Kanumakala Consultant Paediatrician Brighton, UK

Provide preventive counseling to parents and patients with specific endocrine conditions about:

Prescribing Guidelines Prescribing arrangement for the management of patients transferring from Secondary Care to Primary Care

Children s Hospital & Research Center Oakland. Endocrinology

CIGNA HealthCare Prior Authorization Form - Growth Hormone Medications -

9.4 Regulating the Reproductive System

FLASH CARDS. Kalat s Book Chapter 11 Alphabetical

Clinical Guideline ADRENARCHE MANAGEMENT OF CHILDREN PRESENTING WITH SIGNS OF EARLY ONSET PUBIC HAIR/BODY ODOUR/ACNE

The Adolescent: A Patient at Risk: Ovarian Failure in Adolescent Cancer Survivors

First Name. Specialty: Fax. First Name DOB: Duration:

Hormonal Control of Human Reproduction

Endocrine: Precocious Puberty Health care guidelines for Spina Bifida

Reproductive physiology

Preface Acknowledgments Introduction Introductory Concepts Definitions and Context Chronological Age and Age Groups Why Study These Phenomena?

TRANSITIONING FROM A PEDIATRIC TO AN ADULT ENDOCRINOLOGIST CARLOS A. LEYVA JORDÁN, M.D. PEDIATRIC ENDOCRINOLOGIST

Growth hormone therapy for short stature in adolescents the experience in the University Medical Unit, National Hospital of Sri Lanka

Reproductive System. Testes. Accessory reproductive organs. gametogenesis hormones. Reproductive tract & Glands

Reproductive Hormones

4/23/2015. Pediatric Growth Hormone Deficiency: Identification, Diagnosis, & Management. Conflict of Interest. Objectives THANK YOU!

General Approval Criteria for ALL Growth Hormone agents: (ALL criteria must be met)

AETNA BETTER HEALTH Non-Formulary Prior Authorization guideline for Growth Hormone and related agents

Elements for a Public Summary

Management of Pediatric Fibrous Dysplasia/McCune-Albright Syndrome

Clinical Guideline POSITION STATEMENT ON THE INVESTIGATION AND TREATMENT OF GROWTH HORMONE DEFICIENCY IN TRANSITION

PHARMACY POLICY STATEMENT Indiana Medicaid

PHARMACY POLICY STATEMENT Indiana Medicaid

TURNERS SYNDROME. Mike Chan Alex Sproul Casey Sully 11/24/08

Growing up. W Worksheet 3.1: Percentile growth charts

PREP Pediatric Endocrinology General session. Srinath Sanda, M.D. UC San Francisco

Bio 12- Ch. 21: Reproductive System

Tower Hamlets GPs and Barts Health NHS Trust Shared Care Guidelines. TRIPTORELIN Central Precocious Puberty. Patient Name : Date of Birth: NHS No:

Somatostatin Analog and Estrogen Treatment in a Tall Girl

Clinical evaluation of infertility

GROWTH ASSESSMENT AND GROWTH DISORDERS. IAP UG Teaching slides

Hyperprolactinemia in A 15-Year-Old Girl with Primary Amenorrhea

Correlation of Serum Follicular Stimulating Hormone

Supplemental Data: Detailed Characteristics of Patients with MKRN3. Patient 1 was born after an uneventful pregnancy. She presented in our

Dr. Nermine Salah El-Din Prof of Pediatrics

Action of reproductive hormones through the life span 9/22/99

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY & MOLECULAR BIOLOGY

ENDOCRINE SYSTEM 29 MAY 2013

Prior Authorization Criteria Form This form applies to Paramount Commercial Members Only. Non-Preferred Growth Hormone Products

Reproductive physiology. About this Chapter. Case introduction. The brain directs reproduction 2010/6/29. The Male Reproductive System

2-year-old girl with premature thelarche. Endorama February 5, 2015 Carmen Mironovici, M.D.

Female Reproductive System. Lesson 10

Why Reproduce? In order to ensure the continuation of the species and the continuation of life in general by producing offspring

Growth, Development, Nutrition & Ageing Module Year 2 Semester II (2014/15 Batch)

HORMONES & REPRODUCTION OUTLINE

Outline. Male Reproductive System Testes and Sperm Hormonal Regulation

Date: 24 April-2007 Trial ID: GHTUR/E/2 Version: 2 Integrated Clinical Trial Report Status: Final ICTR Synopsis Page: 1 of 5

ROTATION SUMMARY ENDOCRINOLOGY

Puberty and Fertility. Normal Female Puberty PUBERTY! What about girls with Galactosemia? E Puberty and Fertility Badik Spencer 1

Linear Growth Assessment: Evaluation and Causes and Treatment of Growth Failure

GUIDELINES ON. Introduction. G.R. Dohle, S. Arver, C. Bettocchi, S. Kliesch, M. Punab, W. de Ronde

Genotropin, Norditropin, Nutropin, Nutropin AQ, Humatrope, Saizen,

PITUITARY: JUST THE BASICS PART 2 THE PATIENT

Endocrine Late Effects in Survivors of Pediatric SCT

Growth Hormone Therapy

Growth Hormone Deficiency in Young Adults Series 7. Patient s Guide. Average Readability Leaflet

GROWTH HORMONE DEFICIENCY AND OTHER INDICATIONS FOR GROWTH HORMONE THERAPY CHILD AND ADOLESCENT

to ensure the. Sexual reproduction requires the (from the mother) by a (from the father). Fertilization is the fusion of.

Study Guide Answer Key Reproductive System

Female Reproductive Physiology. Dr Raelia Lew CREI, FRANZCOG, PhD, MMed, MBBS Fertility Specialist, Melbourne IVF

Circle Yes or No Y N. [If yes, skip to question 30.] 2. Is this request for a child? Y N. [If no, skip to question 20.]

Phases of the Ovarian Cycle

Laboratory Investigation of Male Gonadal Function. Dr N Oosthuizen Dept of Chemical Pathology UP 2010

Evaluation of Failure to Thrive in a Young Child: Case Example of Jeff. Andrew Hsi, MD, MPH Family Medicine Pediatric Grand Rounds, 8 August 2012

15) Presenting Problems in Reproductive Disease Dr. Taha

PFIZER INC. Study Centre: One centre from Hungary enrolled subjects in this study

Early or late childhood? Age driven. LH driven Start testosterone when LH begins to rise Indicates that the pituitary is trying and failing

Endocrine Features of Fibrous Dysplasia/McCune-Albright Syndrome

Join the Turner Syndrome Foundation Professional Registry. Name: Title/Speciality: Affiliation: Business Name: Address: Address: City: State: Zip:

Klinefelter syndrome ( 47, XXY )

Conflict of Interest Disclosure. No conflict of interest to disclose

Transcription:

Growth and Puberty: A clinical approach Dr Esko Wiltshire

NOTHING TO DISCLOSE

Why is this character short?

Food Psychosocial factors Major Systems (+drugs) Genetic potential Perinatal Classical Hormones Endocrine Growth Factors Endocrine/Paracrine/ Autocrine

Hormones through the life cycle Prenatal Birth Adult Neonatal period Senescence Childhood

What initiates puberty? Gonad independent increase in GnRH release Balance between inhibitory and excitatory inputs to the approx 1000 GnRH secreting neurones Complex neuronal networks Glial cells also modify inputs, via secretion of growth factors Transsynaptic: Inhibitory pathways: GABA, enkephalin Excitatory: glutaminergic, Kiss-1 Glial: Excitatory only

What initiates puberty? Nutrition Genetic Factors Skeletal Maturity

Clinical Pubertal Assessment Tanner Stages Breast Pubic Hair Genitalia Testicular volume

Case 1 What do you think about this growth chart? What else would you like to know to assess the patient?

Normal Variants Genetic/Familial Short stature Constitutional Delay of Growth and Development

Normal Variants: GV normal Familial Constitutional Delay Height < -2 S.Ds < -2 S.Ds Bone age =chronological <chronological Puberty Normal Delayed Growth Velocity Normal Normal Final Height Short Normal/Tall Parents Short Normal Family History Positive (for short stature) Positive (for constitutional)

Case 2 What is this well known character short?

Hypopituitarism 60 years old History of x 50 head injuries! Immature appearance Rippled central obesity Proportionate short stature CMAJ 2004; 171 (12):1433

Pathological Causes: GV abnormal Other Systems Subclinical GI/renal disease Psychosocial (neglect) History Small for gestational age Genes Turner syndrome Skeletal dysplasia Syndromes

Pathological Causes Hormones Thyroid deficiency Growth hormone deficiency Glucocortiocoid excess Combinations: Pituitary Congenital (eg septo-optic dysplasia) Acquired (Eg tumour, irradiation, significant head injury) :Hypothalamus Any simple clinical clues to these? Short and Fat

Approach History Height measured accurately and over time Mid-parental height Perinatal history Past history (including previous significant head injury, surgery, drugs, etc) Family history Systems Psychosocial Development

Approach Examination Growth parameters (auxology) Dysmorphic features Proportions Blood pressure Fundi and visual fields Thyroid (goitre, hypothyroidism) General (chronic disease with limited symptoms)

Investigation Bone Age Other investigations depend on your clinical assessment and particularly growth velocity All girls with significant short stature require a karyotype

Treatment Treat the cause Growth hormone Growth hormone deficiency Turner syndrome Chronic renal failure Intrauterine growth redardation Prader Willi Syndrome Severe idiopathic short stature (trial) Androgens Consider in constitutional delay

Case 3: Miss CB - 2.5 year old girl

Growth in Turner Syndrome Short stature is one of the commonest things that happens in Turner syndrome Most girls are short Almost all girls are short for their family Important growth genes on the X-chromosome (esp SHOX gene) Altered tempo of growth

What can we do about Growth? Growth hormone therapy Lots of studies have shown that growth hormone improves the speed of growth and final height The earlier it starts the better the long-term effect Dose of growth hormone is also important With early start can normalise final height Additional benefits: Bones, timing of puberty

Recent developments with growth Growth Hormone plus Childhood Low-Dose Estrogen in Turner s Syndrome. Ross J, Quigley C et al: N Engl J Med 364:1230-1242 Randomised study in 150 girls age 5-12.5 years with 4 groups: Placebo Very low dose estrogen Growth hormone Growth hormone plus very low dose estrogen (Type of estrogen used no longer available)

Results Growth hormone treatment improved final height by around 5 cm Additional very low dose estrogen added further 2.2 cm to this Relatively late therapy in some of the girls Given 3 times a week rather than daily (less effective) Toddler study: JCEM 2007, Davenport ML, Quigley CA. Early growth hormone therapy corrects the early growth impairment in Turner syndrome

Low dose estrogen also appeared to improve some other things: Speed of processing some information Motor function Memory

Progress She is now 12 years old What should we do about puberty?

Pubertal Induction Somewhere between 5 and 25% of do commence puberty spontaneously (depending on chromosomes) Usually doesn t progress Need to see a high FSH before starting Most girls will need pubertal induction or estrogen supplementation at some point

Timing Balance: Growth (delaying a bit gives you longer to grow) Being on par with peers (aim for usual timing of puberty) Uterine development Improves chances of carrying a pregnancy Individual decision. Early growth hormone treatment generally means you can start this sooner (on par with peers), but with late diagnosis sometimes worth delaying Ideally start before 14 to maximise uterine growth

How to do it? Mimic natural puberty Slowly increasing doses of estrogen over 2.5-3 years Progesterone later in the process (cyclical) Normal menstruation Healthy endometrium Initially very low doses Symmetrical breast development Type of estrogen: As natural as possible Oral, transdermal, combined

Transdermal Estrogen Matrix patches (estrogen imbedded in a membrane applied to skin) Can cut the patch to a very small size, which allows the right dose to be given Evidence that topical estrogen leads to better uterine growth than oral estrogen Special Authority limits for topical estrogen Occasionally not tolerated because of skin reactions

Outcomes Feminisation Uterine growth Healthy Bones (acquisition of bone mass) Cessation of growth

Miss CB has now completed puberty and is 16 years old Are there any other issues you should think about as her GP?

Transition to adulthood Moving on to adult life healthy School/Learning Bones Hearing Heart

School/Learning Addressing individual learning needs through-out childhood Specific learning issues Practical assistance with important exams Addressing anxiety, etc

Bones Normal Osteoporosis

Bones Obtain maximal peak bone mass Healthy nutrition Exercise (weight bearing) Growth hormone Estrogen Monitoring (DXA at end of puberty) Maintain Bone Health (Prevent excess loss of bone) Healthy nutrition (incl dietary vitamin D and calcium/phosphate) Exercise (weight bearing) On-going estrogen (continuous).. Probably not the OC Early Diagnosis therefore critical

Hearing Screening for sensorineural hearing loss

Heart Monitoring of Blood Pressure Reassessing heart/major blood vessels ECHO and/or MRI Critical if contemplating pregnancy

Case 4: 5 year old girl What do you notice on the following slides and what would you do about it?

Premature thelarche (benign) verses true precocious puberty When should puberty start?

Normal Pubertal Variants Neonatal Mini-Puberty Premature Thelarche Premature Adrenarche Gynaecomastia

Why is this character short?

Turner syndrome Linda Hunt

Summary take home points Most growth and pubertal disorders can be sorted out with a standard clinical approach Normal variants of both growth and puberty are common. Pathological causes are less common but have clinical clues Bone age is very useful (don t do lots of tests) Measure children s heights as well as weight when they come to see you Previous measurements and calculation of growth velocity is often the most important thing Turner syndrome is not uncommon, is multisystemic and needs follow-up/anticipatory guidance across the whole life cycle Do a karyotype in any girls below 5 th centile or with additional clinical features

More Reliable Height Measurement Appropriate measuring device (stadiometer) Calibrate frequently (before and after each session) Single trained observer (yourself) Careful positioning of child (stretch gently) Measure without reference to previous heights Measure at beginning and end of examination